Axa’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,702
| Closed | -$423K | – | 1332 |
|
|
2021
Q2 | $423K | Sell |
6,702
-42,305
| -86% | -$2.67M | ﹤0.01% | 1125 |
|
|
2021
Q1 | $6.04M | Sell |
49,007
-3,701
| -7% | -$456K | 0.02% | 659 |
|
|
2020
Q4 | $6M | Buy |
52,708
+877
| +2% | +$99.8K | 0.02% | 651 |
|
|
2020
Q3 | $6.2M | Buy |
51,831
+574
| +1% | +$68.6K | 0.02% | 567 |
|
|
2020
Q2 | $6.39M | Buy |
51,257
+40,524
| +378% | +$5.05M | 0.03% | 545 |
|
|
2020
Q1 | $2.07M | Buy |
+10,733
| New | +$2.07M | 0.01% | 728 |
|